Investment: “Hope Care raises €6 million”
Hope Care, a Portuguese digital health company specialising in regulated remote patient monitoring technology, has closed a €6 million Series A round led by Iberis Capital.
The round included participation from Vieira de Matos – VDM Capital, S.A. and existing shareholder Buenavista Equity Partners.
Founded in 2012 and led by founder and CEO José Paulo Carvalho, Hope Care develops OpMA, a regulated platform that powers centralised remote care and telehealth centres. The company says the platform brings together medical device data, patient-reported outcomes and clinical workflows in a single environment, enabling healthcare organisations to design, deploy and scale digital care programmes across multiple chronic conditions to support proactive intervention and more efficient care delivery.
Hope Care currently delivers remote patient monitoring programmes in Portugal and France and has a project underway in Switzerland. It has established Hope Care GmbH in Germany, headquartered at Medical Valley in Erlangen, with a first German deployment scheduled to launch in October 2026, and is advancing a project and local presence in Romania with setup activities due to begin by the end of September 2026. In Portugal the technology is used by 15 Local Health Units covering approximately 45% of all registered SNS users, as well as the Regional Health Services of Madeira and the Azores, and is also deployed across private healthcare providers, social care organisations and municipalities. The company reports measurable clinical and economic impact, citing a 12-month analysis of 43 people living with chronic obstructive pulmonary disease that was associated with a 76% reduction in hospital days, a 74% reduction in emergency department visits and estimated annual savings of €4,811 per patient. Hope Care also reported first-half sales in 2026 reached 2.5 times the first-half level of 2025.
Hope Care plans to use the funding to support continued expansion across Europe, strengthen its commercial and operational capabilities, and accelerate the deployment of remote patient monitoring programmes in key healthcare markets.
“This Series A marks a new stage for Hope Care. After more than a decade working with healthcare institutions, we have built a regulated platform that delivers measurable outcomes for patients, healthcare professionals and healthcare systems. With the support of our investors, we are now well positioned to accelerate our European expansion and bring this model of care to more healthcare organisations.” — José Paulo Carvalho
“Across Europe, health systems are straining under the weight of chronic disease, still responding to crises rather than preventing them. Hope Care is one of the few companies that pairs proven clinical evidence with the regulatory maturity to operate inside public health systems at scale. This is a model we are proud to help scale across Europe, since it helps clinicians improve outcomes for patients and ultimately the sustainability of care,” said João Henriques, Partner at Iberis Capital.
